France · Pre-seed startup

Who invested in EndoGene.Bio

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Big Data & Analytics

Funding summaryUpdated 26 Oct 2026

$3.1Mraised across 1 round since 2023, from 1 source

Latest round
Pre-seed, $3.1MJun 2023
Investors
3
See who backed them

The rounds

  1. Jun 2023

Founders and team

From EndoGene.Bio's own website: 5 on the team.

  • Jose Ignacio ZaballosHead of IT & Infrastructure
  • Sophie MinaHead of Finance and Operations
  • Lorea IturriClinical Manager
  • Sophie RibeiroSenior Lab Specialist
  • Timothée Pereira KraemerOffice Manager and Executive Assistant

Everyone who backed them

Entrepreneur FirstAccelerator1round
AtomicoVC firm1round
Frontline VenturesVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about EndoGene.Bio

Who invested in EndoGene.Bio?

EndoGene.Bio's investors include Entrepreneur First, Atomico and Frontline Ventures.

How much has EndoGene.Bio raised?

EndoGene.Bio has raised $3.1M across 1 round since 2023.

When did EndoGene.Bio last raise?

EndoGene.Bio's most recent round was a Pre-seed of $3.1M in Jun 2023.

What was EndoGene.Bio's biggest round?

Its most recent round, $3.1M in Jun 2023, is also its largest on record.

Who backed EndoGene.Bio first?

EndoGene.Bio's first round on record, in Jun 2023, was backed by Entrepreneur First, Atomico and Frontline Ventures.

What stage is EndoGene.Bio at?

EndoGene.Bio's latest named round is a Pre-seed, in Jun 2023.

Where is EndoGene.Bio based?

EndoGene.Bio is based in France.

Companies like EndoGene.Bio

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.